Asia Pacific Joint Pain Injection Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Drugs (Hyaluronic Acid, Corticosteroid, and Others), Joint Type (Knee, Foot and Ankle, Shoulder and Elbow, Hip, and Others), and Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, and Others)
Market Introduction
The Asia Pacific joint pain injection market is a highly fragmented market with the presence of considerable regional and local players providing numerous solutions for companies investing in the market arena. Hyaluronic acid injections offered by companies are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function. Corticosteroids are also used to treat sports-related injuries. The growing pharmaceutical and biopharmaceutical production and rising research and development in the country have leveraged the joint pain injection market's growth. The other indirect leading factors, such as increasing incidences of chronic diseases and growing geriatric population, contribute to the market's growth. The growing partnerships with various international companies have also resulted in increasing innovations that are offering growth opportunities for the market. Also, penetration of international companies in Japan is likely to favor the growth of the market. For instance, an American biotechnology company, Genzyme Corp’s Synvisc, used to treat osteoarthritis of the knee, has been approved in Japan.
Several Asia Pacific countries witnessed an unprecedented rise in the number of COVID-19 cases, which led to the discontinuation of several business operations and manufacturing activities of various healthcare products, including joint pain injections, which negatively impacted the joint pain injection market during the early months of 2020. Staff quarantine, supply-chain failures, and reductions in demand have generated serious complications for companies. Also, there has been a significant drop in in-patient and out-patient for private hospital chains. In an effort to relieve healthcare systems, many clinics have been postponing non-critical surgeries. To avoid overburdening hospitals, already struggling to deal with the rising pandemic pressure, doctors are delaying surgeries till the Covid-19 peak is past. Moreover, medical device companies are starting to forecast large sales declines in their Chinese markets because people are staying at home. Many big medical device companies such as Stryker, CartiHeal Inc., and Smith & Nephew have predicated the decline in sales in china. Hospitals across China, Hong Kong and Taiwan have been deferring orthopedic surgeries, to prevent the spread of the virus in the region. Almost no elective surgeries were performed in China in February. Such drop in number of elective surgeries is estimated to deter the Asia Pacific joint pain injection market by 2028.
Get more information on this report :
Market Overview and Dynamics
The joint pain injection market in Asia Pacific is expected to grow from US$ 401.96 million in 2021 to US$ 675.90 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2021 to 2028. The healthcare industry in the region has been witnessing rapid transformation during the years. Also, various factors promoting the growth of healthcare industry include, rising prevalence of orthopedic diseases, ageing population, increasing income and affordability, leading to higher demand and utilization of healthcare services. Asia Pacific has various growth opportunities due to rising medical tourism that demand technologically advanced medical technologies, consistently growing demand for orthopedic therapies. Furthermore, various international market players are shifting their manufacturing plants to India, which is expected to drive market growth significantly during the forecast period.
Key Market Segments
Based on drugs, the hyaluronic acid segment accounted for the largest share of the Asia Pacific joint pain injection market in 2020. Based on joint type, the knee segment accounted for the largest share of the Asia Pacific joint pain injection market in 2020. Based on distribution channel, the hospital pharmacies segment accounted for the largest share of the Asia Pacific joint pain injection market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Asia Pacific joint pain injection market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report include Chugai Pharmaceutical Co., Ltd.; Bioventus Inc.; Fidia Pharma USA Inc.; Seikagaku Corporation; Ferring B.V.; Sanofi; Anika Therapeutics, Inc. and Teva Pharmaceutical Industries Ltd..
Reasons to buy report
- To understand the Asia Pacific joint pain injection market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific joint pain injection market
- Efficiently plan M&A and partnership deals in Asia Pacific joint pain injection market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific joint pain injection market
- Obtain market revenue forecast for market by various segments from 2020-2028 in Asia Pacific region.
Asia Pacific Joint Pain Injection Market Segmentation
Asia Pacific Joint Pain Injection Market -By Drugs
- Hyaluronic Acid
- Corticosteroid
- Others
Asia Pacific Joint Pain Injection Market -By Joint Type
- Knee
- Foot and Ankle
- Shoulder and Elbow
- Hip
- Others
Asia Pacific Joint Pain Injection Market -By Distribution Channel
- Retail Pharmacies
- Hospitals Pharmacies
- Others
Asia Pacific Joint Pain Injection Market – By Country
- US
- Canada
- Mexico
Asia Pacific Joint Pain Injection Market – Company Profiles
- Chugai Pharmaceutical Co., Ltd.
- Bioventus Inc.
- Fidia Pharma USA Inc.
- Seikagaku Corporation
- Ferring B.V.
- Sanofi
- Anika Therapeutics, Inc.
- Teva Pharmaceutical Industries Ltd.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Joint Pain Injection Market – By Drugs
1.3.2 Asia Pacific Joint Pain Injection Market – By Joint Type
1.3.3 Asia Pacific Joint Pain Injection Market – By Distribution Channel
1.3.4 Asia Pacific Joint Pain Injection Market – By Country
2. Asia Pacific Joint Pain Injection Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Joint Pain Injection – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. Joint Pain Injection Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in the Prevalence of Musculoskeletal Disorders
5.1.2 An Upsurge in the Number of Sports Injuries
5.2 Market Restraints
5.2.1 High Costs Associated with Joint Repair Therapies
5.3 Market Opportunities
5.3.1 Growth of Pharmaceutical Sector in Emerging Markets
5.4 Future Trends
5.4.1 Development of Innovative Products
5.5 Impact Analysis
6. Joint Pain Injection Market – Asia Pacific Analysis
6.1 Asia Pacific Joint Pain Injection Market Revenue Forecast and Analysis
6.2 Asia Pacific Joint Pain Injection Market, By Country - Forecast and Analysis
7. Asia Pacific Joint Pain Injection Market Analysis – By Drugs
7.1 Overview
7.2 Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)
7.3 Hyaluronic Acid
7.3.1 Overview
7.3.2 Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Corticosteroid
7.4.1 Overview
7.4.2 Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Joint Pain Injection Market Analysis – By Joint Type
8.1 Overview
8.2 Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)
8.3 Knee
8.3.1 Overview
8.3.2 Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hip
8.4.1 Overview
8.4.2 Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Foot and Ankle
8.5.1 Overview
8.5.2 Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Shoulder and Elbow
8.6.1 Overview
8.6.2 Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Joint Pain Injection Market Analysis – By Distribution Channel
9.1 Overview
9.2 Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028, (%)
9.3 Hospitals Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Joint Pain Injection Market – Country Analysis
10.1 Asia Pacific: Joint Pain Injection Market Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 Asia Pacific: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
10.1.3 China: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 China: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2 China: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.3.3 China: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.3.4 China: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.4 Japan: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Japan: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Japan: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.4.3 Japan: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.4.4 Japan: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.5 India: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.1 India: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.2 India: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.5.3 India: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.5.4 India: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6 South Korea: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1 South Korea: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 South Korea: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.6.3 South Korea: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.6.4 South Korea: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.7 Australia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.1 Australia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.2 Australia: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.7.3 Australia: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.7.4 Australia: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.8 Rest of Asia Pacific: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Rest of Asia Pacific: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Rest of Asia Pacific: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)
10.1.8.3 Rest of Asia Pacific: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)
10.1.8.4 Rest of Asia Pacific: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Asia Pacific Joint Pain Injection Market
11.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12. Asia Pacific Joint Pain Injection Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Chugai Pharmaceutical Co., Ltd.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bioventus Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Fidia Pharma USA Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Seikagaku Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ferring B.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Sanofi
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Anika Therapeutics, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Teva Pharmaceutical Industries Ltd.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Joint Pain Injection Market –Revenue and Forecast To 2028 (US$ Million)
Table 2. China Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 3. China Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 4. China Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 5. Japan Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 6. Japan Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 8. India Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 9. India Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 10. India Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. South Korea Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 12. South Korea Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 13. South Korea Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 14. Australia Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 15. Australia Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Australia Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Asia Pacific Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Asia Pacific Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Asia Pacific Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms, Joint Pain Injection Market
LIST OF FIGURES
Figure 1. Joint Pain Injection Market Segmentation
Figure 2. Asia Pacific Joint Pain Injection Market Segmentation, By Country
Figure 3. Joint Pain Injection Market Overview
Figure 4. Knee Joint Type Segment Held Largest Share of Joint Pain Injection Market
Figure 5. China to Show Significant Growth During Forecast Period
Figure 6. Asia Pacific Joint Pain Injection Market, Industry Landscape
Figure 7. Asia Pacific PEST Analysis
Figure 8. Joint Pain Injection Market Impact Analysis of Driver and Restraints
Figure 9. Asia Pacific Joint Pain Injection Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)
Figure 11. Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)
Figure 15. Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028 (%)
Figure 21. Hospital Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Asia Pacific: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)
Figure 25. Asia Pacific: Joint Pain Injection Market, by Country, 2020 & 2028 (%)
Figure 26. China: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Japan: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. India: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. South Korea: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Australia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Rest of Asia Pacific: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
- Chugai Pharmaceutical Co., Ltd.
- Bioventus Inc.
- Fidia Pharma USA Inc.
- Seikagaku Corporation
- Ferring B.V.
- Sanofi
- Anika Therapeutics, Inc.
- Teva Pharmaceutical Industries Ltd.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific joint pain injection market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific joint pain injection market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific joint pain injection market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distributiona